Wang, Weijun <br/><br/>
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.  [electronic resource] 

 -  British journal of pharmacology  02 2018 
 - 469-484 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5381 
<br/><br/><label>Standard No.: </label>10.1111/bph.14095  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Caco-2 Cells<br/>Diet, High-Fat--adverse effects<br/>Gastrointestinal Microbiome--drug effects<br/>Humans<br/>Intestine, Small--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Non-alcoholic Fatty Liver Disease--drug therapy<br/>Random Allocation<br/>Taurochenodeoxycholic Acid--pharmacology